BridgeBio Pharma, Inc. (BBIO) › Total LiabilitiesBridgeBio Pharma, Inc. (BBIO) — Total LiabilitiesAnnual figures by period end, from SEC filings.2018-12-31: $87.58M2019-12-31: $155.70M2020-12-31: $595.70M2021-12-31: $1.88B2022-12-31: $1.87B2023-12-31: $1.89B2024-12-31: $2.38B2025-12-31: $3.01B$3.01B2018-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$3.01B+26.7%2026-02-24Balance as of period end2024-12-31$2.38B+25.8%2026-02-24Balance as of period end2023-12-31$1.89B+1.1%2025-02-20Balance as of period end2022-12-31$1.87B-0.6%2024-02-22Balance as of period end2021-12-31$1.88B+215.3%2023-02-23Balance as of period end2020-12-31$595.70M+282.6%2022-02-25Balance as of period end2019-12-31$155.70M+77.8%2021-02-25Balance as of period end2018-12-31$87.58M—2020-03-03Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)